FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584255576> ?p ?o ?g. }

• W2584255576 endingPage "1505" @default.
• W2584255576 startingPage "1494" @default.
• W2584255576 abstract "Background: Although small elevations of high-sensitive cardiac troponin T (hs-cTnT) are associated with incident heart failure (HF) in the general population, the underlying mechanisms are not well defined. Evaluating the association of hs-cTnT with replacement fibrosis and progression of structural heart disease before symptoms is fundamental to understanding the potential of this biomarker in a HF prevention strategy. Methods: We measured hs-cTnT at baseline among 4986 participants in MESA (Multi-Ethnic Study of Atherosclerosis), a cohort initially free of overt cardiovascular disease (CVD). Cardiac magnetic resonance imaging was performed at baseline. Repeat cardiac magnetic resonance was performed 10 years later among 2831 participants who remained free of interim CVD events; of these, 1723 received gadolinium-enhanced cardiac magnetic resonance for characterization of replacement fibrosis by late gadolinium enhancement. Progression of subclinical CVD was defined by 10-year change in left ventricular structure and function. Associations of hs-cTnT with incident HF, CV-related mortality, and coronary heart disease were estimated using Cox regression models. Results: Late gadolinium enhancement for replacement fibrosis was detectable in 6.3% participants without interim CVD events by follow-up cardiac magnetic resonance. A graded association was observed between higher baseline hs-cTnT categories and late gadolinium enhancement (≥7.42 ng/L versus <limit of detection [<3 ng/L]; adjusted odds ratio, 2.87; 95% confidence interval, 1.38–5.94). Higher hs-cTnT was also associated with a greater probability of an increase in LV mass >12% (highest category versus <limit of detection; odds ratio, 1.50; 95% confidence interval, 1.09–2.07), but not with decline in left ventricular ejection fraction. The risk of incident HF was greater for higher hs-cTnT (≥8.81 ng/L versus <limit of detection; adjusted hazards ratio, 5.59; 95% CI, 2.97–10.68). Conclusions: hs-cTnT levels are associated with replacement fibrosis and progressive changes in left ventricular structure in CVD-free adults, findings that may precede HF symptoms by years. Minor elevations of hs-cTnT may represent a biochemical signature of early subclinical cardiac disease, providing an opportunity for targeted preventive interventions." @default.
• W2584255576 created "2017-02-10" @default.
• W2584255576 creator A5004246558 @default.
• W2584255576 creator A5005312014 @default.
• W2584255576 creator A5029186856 @default.
• W2584255576 creator A5035106740 @default.
• W2584255576 creator A5038689387 @default.
• W2584255576 creator A5048308230 @default.
• W2584255576 creator A5051212717 @default.
• W2584255576 creator A5071573513 @default.
• W2584255576 creator A5089603612 @default.
• W2584255576 date "2017-04-18" @default.
• W2584255576 modified "2023-10-17" @default.
• W2584255576 title "High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure" @default.
• W2584255576 cites W139699688 @default.
• W2584255576 cites W1717470955 @default.
• W2584255576 cites W1815297513 @default.
• W2584255576 cites W1941358101 @default.
• W2584255576 cites W1976322287 @default.
• W2584255576 cites W1987814308 @default.
• W2584255576 cites W1989687645 @default.
• W2584255576 cites W2009826381 @default.
• W2584255576 cites W2019669602 @default.
• W2584255576 cites W2024081693 @default.
• W2584255576 cites W2033969839 @default.
• W2584255576 cites W2044336787 @default.
• W2584255576 cites W2063260491 @default.
• W2584255576 cites W2076335162 @default.
• W2584255576 cites W2085607733 @default.
• W2584255576 cites W2101976312 @default.
• W2584255576 cites W2112446953 @default.
• W2584255576 cites W2113258585 @default.
• W2584255576 cites W2114157611 @default.
• W2584255576 cites W2114163432 @default.
• W2584255576 cites W2115830594 @default.
• W2584255576 cites W2117913791 @default.
• W2584255576 cites W2119340816 @default.
• W2584255576 cites W2121179755 @default.
• W2584255576 cites W2126617656 @default.
• W2584255576 cites W2130356761 @default.
• W2584255576 cites W2133222316 @default.
• W2584255576 cites W2155820750 @default.
• W2584255576 cites W2155965977 @default.
• W2584255576 cites W2156097706 @default.
• W2584255576 cites W2159683035 @default.
• W2584255576 cites W2178738676 @default.
• W2584255576 cites W2182153635 @default.
• W2584255576 cites W2196906371 @default.
• W2584255576 cites W2469805673 @default.
• W2584255576 cites W2607031541 @default.
• W2584255576 cites W2764148593 @default.
• W2584255576 cites W4211082352 @default.
• W2584255576 doi "https://doi.org/10.1161/circulationaha.116.025505" @default.
• W2584255576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5401621" @default.
• W2584255576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28159799" @default.
• W2584255576 hasPublicationYear "2017" @default.
• W2584255576 type Work @default.
• W2584255576 sameAs 2584255576 @default.
• W2584255576 citedByCount "135" @default.
• W2584255576 countsByYear W25842555762017 @default.
• W2584255576 countsByYear W25842555762018 @default.
• W2584255576 countsByYear W25842555762019 @default.
• W2584255576 countsByYear W25842555762020 @default.
• W2584255576 countsByYear W25842555762021 @default.
• W2584255576 countsByYear W25842555762022 @default.
• W2584255576 countsByYear W25842555762023 @default.
• W2584255576 crossrefType "journal-article" @default.
• W2584255576 hasAuthorship W2584255576A5004246558 @default.
• W2584255576 hasAuthorship W2584255576A5005312014 @default.
• W2584255576 hasAuthorship W2584255576A5029186856 @default.
• W2584255576 hasAuthorship W2584255576A5035106740 @default.
• W2584255576 hasAuthorship W2584255576A5038689387 @default.
• W2584255576 hasAuthorship W2584255576A5048308230 @default.
• W2584255576 hasAuthorship W2584255576A5051212717 @default.
• W2584255576 hasAuthorship W2584255576A5071573513 @default.
• W2584255576 hasAuthorship W2584255576A5089603612 @default.
• W2584255576 hasBestOaLocation W25842555761 @default.
• W2584255576 hasConcept C113280763 @default.
• W2584255576 hasConcept C126322002 @default.
• W2584255576 hasConcept C126838900 @default.
• W2584255576 hasConcept C143409427 @default.
• W2584255576 hasConcept C164705383 @default.
• W2584255576 hasConcept C2776008845 @default.
• W2584255576 hasConcept C2778198053 @default.
• W2584255576 hasConcept C2908647359 @default.
• W2584255576 hasConcept C3018763269 @default.
• W2584255576 hasConcept C36036425 @default.
• W2584255576 hasConcept C44249647 @default.
• W2584255576 hasConcept C500558357 @default.
• W2584255576 hasConcept C50382708 @default.
• W2584255576 hasConcept C71924100 @default.
• W2584255576 hasConcept C72563966 @default.
• W2584255576 hasConcept C8880881 @default.
• W2584255576 hasConcept C99454951 @default.
• W2584255576 hasConceptScore W2584255576C113280763 @default.
• W2584255576 hasConceptScore W2584255576C126322002 @default.
• W2584255576 hasConceptScore W2584255576C126838900 @default.
• W2584255576 hasConceptScore W2584255576C143409427 @default.

• next